CS258143B2 - Method of crystalline solavate production - Google Patents

Method of crystalline solavate production Download PDF

Info

Publication number
CS258143B2
CS258143B2 CS865613A CS561386A CS258143B2 CS 258143 B2 CS258143 B2 CS 258143B2 CS 865613 A CS865613 A CS 865613A CS 561386 A CS561386 A CS 561386A CS 258143 B2 CS258143 B2 CS 258143B2
Authority
CS
Czechoslovakia
Prior art keywords
dimethylformamide
solvate
amino
mol
propen
Prior art date
Application number
CS865613A
Other languages
Czech (cs)
English (en)
Other versions
CS561386A2 (en
Inventor
Leonard B Crast
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of CS561386A2 publication Critical patent/CS561386A2/cs
Publication of CS258143B2 publication Critical patent/CS258143B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/18—7-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
CS865613A 1985-07-29 1986-07-24 Method of crystalline solavate production CS258143B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/759,805 US4694079A (en) 1985-07-29 1985-07-29 3-propenyl cephalosporin solvates

Publications (2)

Publication Number Publication Date
CS561386A2 CS561386A2 (en) 1987-09-17
CS258143B2 true CS258143B2 (en) 1988-07-15

Family

ID=25057020

Family Applications (1)

Application Number Title Priority Date Filing Date
CS865613A CS258143B2 (en) 1985-07-29 1986-07-24 Method of crystalline solavate production

Country Status (17)

Country Link
US (1) US4694079A (fi)
KR (1) KR930004014B1 (fi)
CN (1) CN1015263B (fi)
AR (1) AR243530A1 (fi)
AT (1) AT389876B (fi)
CA (1) CA1262345A (fi)
CS (1) CS258143B2 (fi)
DD (1) DD248594A5 (fi)
EG (1) EG18112A (fi)
ES (1) ES2001338A6 (fi)
FI (1) FI84269C (fi)
GR (1) GR861988B (fi)
HU (1) HU195224B (fi)
NO (1) NO167461C (fi)
PT (1) PT83074B (fi)
SU (1) SU1414317A3 (fi)
YU (1) YU45350B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128336A (en) * 1988-03-23 1992-07-07 Eli Lilly And Company 3-(substituted)-1-carba(dethia)-3-cephems
AT399876B (de) * 1992-02-05 1995-08-25 Biochemie Gmbh Verfahren zur abreicherung von 7-amino-3-((e)-1- propen-1-yl)-3-cephem-4-carbonsäure
JP2825655B2 (ja) * 1992-02-05 1998-11-18 バイオケミ・ゲゼルシヤフト・エム・ベー・ハー ３−セフェム−４−カルボン酸誘導体の精製方法
PT102061B (pt) * 1997-10-08 2000-06-30 J K Ind Ltd Processo de preparacao de um antibiotico cefalosporina geralmente activo-cefixime
EP1447406B1 (en) * 1999-09-30 2006-08-09 Otsuka Kagaku Kabushiki Kaisha 3-Cephem derivative crystal
KR100408430B1 (ko) * 2001-04-18 2003-12-06 한미약품 주식회사 3-(ｚ)-프로페닐 세펨 화합물의 선택적인 제조 방법
US6903211B2 (en) * 2002-10-30 2005-06-07 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of 3-propenyl cephalosporin DMF solvate
US7230097B2 (en) * 2003-03-10 2007-06-12 Lupin Ltd. Process for preparation of 7-[α-Amino (4-hydroxyphenyl) acetamido]-3-substituted-3-cephem-4-carboxylic acid
EP1638520A2 (en) * 2003-06-19 2006-03-29 Ranbaxy Laboratories Limited Solvates of cefprozil
KR100576336B1 (ko) * 2003-10-30 2006-05-03 씨제이 주식회사 세팔로스포린 유도체의 제조방법
US20070072945A1 (en) * 2004-03-31 2007-03-29 Pohoreski Anton Sulphur-containing oils for controlling plant pathogens and stimulating nutrient uptake
EP1809638B1 (en) 2004-11-01 2010-02-17 Hetero Drugs Limited A novel process for preparation of cefprozil intermediate
CN101058584B (zh) * 2007-05-23 2010-05-26 上海骏捷生化科技有限公司 一种制备头孢丙烯母核7-氨基-3-丙烯基头孢烷酸的方法
CN103524533B (zh) * 2013-10-10 2016-01-27 珠海金鸿药业股份有限公司 一种头孢丙烯化合物、其分散片、干混悬剂及制备方法
CN108017658B (zh) * 2017-12-26 2020-06-16 山东裕欣药业有限公司 一种头孢丙烯的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985741A (en) * 1972-09-15 1976-10-12 Bristol-Myers Company Production of p-hydroxycephalexin
DE3381408D1 (de) * 1982-12-27 1990-05-10 Lilly Co Eli Zwischenverbindungen fuer die herstellung von ceftazidin und verfahren zu ihrer herstellung.
US4520022A (en) * 1983-01-28 1985-05-28 Bristol-Myers Company Substituted vinyl cephalosporins

Also Published As

Publication number Publication date
AR243530A1 (es) 1993-08-31
PT83074B (pt) 1989-06-30
CN1015263B (zh) 1992-01-01
DD248594A5 (de) 1987-08-12
FI84269B (fi) 1991-07-31
NO862970L (no) 1987-01-30
HUT41799A (en) 1987-05-28
ATA202886A (de) 1989-07-15
CA1262345A (en) 1989-10-17
GR861988B (en) 1986-12-22
HU195224B (en) 1988-04-28
SU1414317A3 (ru) 1988-07-30
NO167461C (no) 1991-11-06
ES2001338A6 (es) 1988-05-16
FI84269C (fi) 1991-11-11
KR870001216A (ko) 1987-03-12
CS561386A2 (en) 1987-09-17
US4694079A (en) 1987-09-15
YU45350B (en) 1992-05-28
FI863066A0 (fi) 1986-07-25
AT389876B (de) 1990-02-12
NO862970D0 (no) 1986-07-24
PT83074A (en) 1986-08-01
KR930004014B1 (ko) 1993-05-19
NO167461B (no) 1991-07-29
YU131086A (en) 1987-10-31
FI863066A (fi) 1987-01-30
EG18112A (en) 1992-08-30
CN86105568A (zh) 1987-04-01

Similar Documents

Publication Publication Date Title
SU1303029A3 (ru) Способ получени производных цефалоспорина
CS258143B2 (en) Method of crystalline solavate production
SU1487814A3 (ru) СПОСОБ ПОЛУЧЕНИЯ 7-АМИНО-З-[3(4-КАРБАМОИЛ-1-ПИРИДИНИО)-1-ПРОПЕН1-ИЛ]-3-ЦЕФЕМ-4-КАРБОКСИЛАТА ч.
US4714760A (en) Cephalosporin intermediates
EP0113568B1 (en) Intermediates for the preparation of ceftazidine, and process for their preparation
HU195223B (en) Process for producing 7-amino-3-propenyl-3-cefem-4-carboxylic acid and its esters
US4148997A (en) 7-[Sulfomethyl)phenyl]acetamidocephalosporin derivatives
EP0135258B1 (en) Improvements in or relating to a crystalline 7-(r)-amino-3-(1-pyridiniummethyl)-ceph-3-em-4-carboxylate
US3865820A (en) Acylamino-cephalosporanic acids
CA1236089A (en) Ceftazidime
RU2073680C1 (ru) Кристаллические кислотно-аддитивные соли чистых диастереомеров 1-(2,2-диметилпропионилокси)-этилового эфира 3-цефем-4-карбоновой кислоты и способы их получения
US4124762A (en) 7-[(Pyridylthiomethyl)phenyl]acetamido-cephalosporin derivatives
EP0070706B1 (en) Cephalosporin compounds
JPS5973590A (ja) 新規なセフアロスポリン誘導体，その製造法およびそれを含有する抗生物質薬剤
US4959495A (en) Process for the preparation of intermediates used to produce aminothiazoloximino cephalosporins
CA1104560A (en) Pyrrole cephalosporin derivatives
US4692518A (en) Crystalline (7R)-7-amino-3-(1'-pyridiniummethyl)-3-cephem-4-carboxylate monohydrate compound
US4659812A (en) Cephalosporin intermediates
US4124761A (en) 7-[(substituted-thiomethyl)phenyl] acetamidocephalosporin derivatives
US4172942A (en) 7-[(Substituted-thiomethyl)phenyl]acetamidocephalosporin derivatives
US4226806A (en) 7-[(Sulfomethyl)phenyl]acetamidocephalosporin derivatives
US4171434A (en) 7-[(Pyridylthiomethyl)phenyl]acetamidocephalosporin derivatives
US4180661A (en) 7-[(Substituted-isothioureamethyl)phenyl]-acetamidocephalosporin derivatives
JP2662414B2 (ja) チアゾール誘導体
RU2024529C1 (ru) Способ получения производных цефалоспоринов или их солей

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MK4A Patent expired

Effective date: 20010724